National Bank Of Canada /fi/ »

Kyverna Therapeutics shares owned by National Bank Of Canada /fi/

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by National Bank Of Canada /fi/ from 13F filings

Historical chart of National Bank Of Canada /fi/ investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by National Bank Of Canada /fi/ consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by National Bank Of Canada /fi/

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.8k 400 9.39

More positions owned by National Bank Of Canada /fi/

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Rbc Cad (RY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Shopify Cl A Sub Vtg Shs (SHOP)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Cibc Cad (CM)

View all positions for National Bank Of Canada /fi/

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Gilead Sciences
Bain Capital Life Sciences Investors
Deerfield Management Company
Vanguard Group
AIGH Capital Management
Insight Holdings
Woodline Partners
Propel Bio Management
Mbb Public Markets I
Alyeska Investment Group
Millennium Management
BlackRock
RFG Advisory
Susquehanna International

View all funds holding Kyverna Therapeutics